Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in miceA. Rizzi, Girolamo Calò, Raffaella Vergura et al.|British Journal of Pharmacology|2008Cited by 180
Biased versus Partial Agonism in the Search for Safer Opioid AnalgesicsJoaquim Azevedo Neto, Girolamo Calò, Anna Costanzini et al.|Molecules|2020Cited by 77
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonistAnna Rizzi, Girolamo Calò, Maria Camilla Cerlesi et al.|Pharmacology Research & Perspectives|2016Cited by 65
In Vitro and in Vivo Pharmacological Characterization of the Neuropeptide S Receptor Antagonist [d-Cys(tBu)5]Neuropeptide SValeria Camarda, Girolamo Calò, Anna Rizzi et al.|Journal of Pharmacology and Experimental Therapeutics|2008Cited by 57
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68Chiara Ruzza, Girolamo Calò, Anna Rizzi et al.|Peptides|2010Cited by 56